As part of the Prime Minister’s vision for a healthier and more inclusive India, GAIL, in collaboration with AIIMS Delhi, launched a CSR initiative on March 24, 2025, to provide recombinant human growth hormone (rhGH) therapy to pediatric patients with growth hormone deficiency (GHD).

The event was attended by Ms. Bansuri Swaraj, MP, and AIIMS Institute Body Member, Mr. Ayush Gupta, Director (HR), GAIL, and Mr. M. Srinivas, Director, AIIMS, reinforcing their commitment

The post GAIL launched innovative CSR Initiative to provide Recombinant human growth hormone appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.